TxCell S.A.
Stock Exchange Euronext Paris
EPS
EUR0.56
Market Cap
EUR56.25 M
Shares Outstanding
23.2 M
Public Float
11.02 M

Profile

Address
Les Cardoulines HT1
Valbonne-Sophia Antipolis Rhone-Alpes 06560
France
Employees -
Website http://www.txcell.com/index.php/fr
Updated 09/14/2018
TxCell SA is a biotechnology company. The company engages in the research and development of cellular immunotherapy for chronic inflammatory and autoimmune diseases. Its pipeline consists of Ovasave, col treg, lupus, transplantation and car treg dermatology.

Financials

View All
Created with Highcharts 5.0.14TxCell S.A.Net Income. Fiscal year is January-December. All values EUR Thousands.5 4515 4518 2698 26911 29711 29713 57013 57010 91110 9112013201420152016201702.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14TxCell S.A.Sales/Revenue. Fiscal year is January-December. All values EUR Thousands.17171 3271 3279209200000201320142015201620170250500750100012501500

François Meyer
Chairman & Head-Research
Laurent Higueret
Director